ÂÜÀòÂÒÂ×

Paula Hoffmeister-Wittmann is a highly skilled medical professional currently serving as a Resident Doctor and NCT Clinician Scientist Fellow at the National Center for Tumor Diseases (NCT) Heidelberg since May 2022. This position focuses on overcoming chemoresistance and radioresistance in cholangiocarcinoma, evaluating various in vivo models, establishing organoid cultures, and analyzing molecular differences in cholangiocarcinoma subtypes. In addition to this role, Paula has been a Resident Doctor for RadioOncology & Radiation Therapy at Universitätsklinikum Heidelberg from January 2022 to March 2024, concentrating on liver cancer clinical studies. Prior experience includes a Doctoral Student position at NCT Heidelberg where Paula researched the antiapoptotic Bcl-2 protein family in the context of cholangiocarcinoma. Training also encompasses practical years at various esteemed institutions in visceral surgery, hematology-oncology, gastroenterology, and radiology. Paula holds a Dr. med. degree from Heidelberg University and a Staatsexamen in medicine, supplemented by studies at Nantes Université.